Source: Immedicohospitalario.es Bellicum Pharma has reported the preliminary results of its phase I / II dose escalation study in 12 patients with metastatic pancreatic cancer treated […]

Source: Immedicohospitalario.es The studies published by the CNIC scientists during the year 2017 consolidate this center as an institution of Spanish and international research excellence, highlighting […]

Source: immedicohospitalario.es Researchers from the universities of Vienna and Lancaster have developed a method aimed at improving precision medicine already during the clinical development phase of […]

Source: redaccionmedica.com A common medication for diabetes, combined with a drug against high blood pressure, is able to inhibit the growth of tumorese induce the death […]

Source: immedicohospitalario.es Systemic lupus erythematosus (SLE) is an autoimmune disease with multifaceted and extremely variable clinical manifestations, characterized by relapses and outbreaks followed by periods of […]

Source: Laverdad.es Spain has become the second country in the world where more clinical trials are carried out, only surpassed by the United States, the hegemonic […]

Source: redaccionmedica.com Different Spanish biotechnology companies and research groups presented on Wednesday a total of nine advanced innovative drug development projects to representatives of 17 national […]

Source: actasanitaria.com Researchers from the Health Research Institute of the Hospital Clínico de Valencia (INCLIVA) have shown that a molecule used to treat cancer, called PD033299, […]

Source: redaccionmedica.com The great results obtained with CAR-T therapies in cancer patients in whom chemotherapy has failed have focused the day ‘Towards a greater knowledge of […]

Source: redaccionmedica.com AstraZeneca has presented new analyzes of the Pegasus-Timi 54 trial in the framework of the Scientific Conferences of the American Heart Association. These findings […]

Source: actasanitaria.com A day after knowing the draft agreement on Brexit that last Tuesday, November 13, reached the European Union (EU) and the British Government, the […]

Source: actasanitaria.com The European Commission has approved a new indication of enzalutamide, a drug whose trade name is Xtandi and which was registered by the pharmaceutical […]